Gavsy talks have been underway for the next Covid trial between the FDA and MSB and probably the NIH too.
The trial cannot start until we hear from the OTAT...... .... this imposition or delay ( there is that word again ) should be considered negligent by the regulator that made it so given >1500 USA lives alone are being lost each day.
Would have been very easy to audit samples as they went while allowing the trial to start before we heard from OTAT.
Things could happen very quickly once we hear.
Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-786
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |